Spots Global Cancer Trial Database for nanoliposomal irinotecan
Every month we try and update this database with for nanoliposomal irinotecan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma | NCT02022644 | High Grade Glio... | nanoliposomal i... | 18 Years - | University of California, San Francisco | |
| BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma | NCT03119064 | Glioblastoma Mu... Glioblastoma GBM | Nanoliposomal I... Temozolomide | 18 Years - | Brown University | |
| NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | NCT04005339 | Advanced Biliar... | Nanoliposomal I... Leucovorin Fluorouracil | 18 Years - | Georgetown University | |
| A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | NCT05472259 | Metastatic Panc... | Nanoliposomal i... 5 FU Leucovorin Oxaliplatin | 18 Years - | Belgian Group of Digestive Oncology | |
| Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma | NCT05363007 | Metastatic Panc... | nanoliposomal i... spleen irradiat... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | NCT04752696 | Pancreatic Duct... | Onvansertib Nanoliposomal i... Leucovorin Fluorouracil | 18 Years - | Cardiff Oncology | |
| Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy | NCT03712397 | Head & Neck Can... | nanoliposomal i... | 20 Years - | National Health Research Institutes, Taiwan | |
| AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 | NCT06219941 | Gastric Cancer Gastroesophagea... Pancreatic Aden... | AZD0901 5-Fluorouracil Leucovorin l-leucovorin Irinotecan Nanoliposomal I... Gemcitabine | 18 Years - | AstraZeneca | |
| BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma | NCT03119064 | Glioblastoma Mu... Glioblastoma GBM | Nanoliposomal I... Temozolomide | 18 Years - | Brown University | |
| Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors | NCT03810742 | Refractory Soli... | Nanoliposomal I... | 20 Years - 70 Years | PharmaEngine | |
| Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma | NCT02022644 | High Grade Glio... | nanoliposomal i... | 18 Years - | University of California, San Francisco | |
| Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | NCT04752696 | Pancreatic Duct... | Onvansertib Nanoliposomal i... Leucovorin Fluorouracil | 18 Years - | Cardiff Oncology | |
| AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 | NCT06219941 | Gastric Cancer Gastroesophagea... Pancreatic Aden... | AZD0901 5-Fluorouracil Leucovorin l-leucovorin Irinotecan Nanoliposomal I... Gemcitabine | 18 Years - | AstraZeneca | |
| Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine as Conversion Therapy of Locally Advanced Colorectal Cancer | NCT06405139 | Colorectal Canc... | Nanoliposomal I... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | NCT05472259 | Metastatic Panc... | Nanoliposomal i... 5 FU Leucovorin Oxaliplatin | 18 Years - | Belgian Group of Digestive Oncology | |
| Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors | NCT03810742 | Refractory Soli... | Nanoliposomal I... | 20 Years - 70 Years | PharmaEngine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
